Figure 3 illustrates a compelling and clinically relevant pattern in serum AMH levels across three groups: healthy females, Turner syndrome (TS) patients without premature ovarian insufficiency (POI), and TS patients with POI. The gene discussed is AMH; the disease is premature menopause.